op-1250
Showing 1 - 4 of 4
Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)
Not yet recruiting
- Breast Cancer
- +4 more
- OP-1250
- +4 more
- (no location specified)
Aug 31, 2023
Metastatic Breast Cancer, Advanced Breast Cancer, HR-positive Breast Cancer Trial (OP-1250, Ribociclib, Alpelisib)
Not yet recruiting
- Metastatic Breast Cancer
- +3 more
- OP-1250
- +2 more
- (no location specified)
Aug 18, 2022
Breast Cancer Trial in Australia (OP-1250, Palbociclib)
Recruiting
- Breast Cancer
- OP-1250
- Palbociclib
-
Westmead, New South Wales, Australia
- +4 more
Feb 23, 2022
Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer Trial in Australia, United States (OP-1250)
Recruiting
- Hormone Receptor Positive Breast Carcinoma
- HER2-negative Breast Cancer
- OP-1250
-
Orlando, Florida
- +8 more
Oct 22, 2021